Clinical trial
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
NCT03197688 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
- Lead sponsor
- Actelion
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 3, 2017
- Completion date
- September 6, 2018
- Enrollment
- 2,200 (actual)
- Sites
- 106
Conditions
As the registry lists them; a condition with its own page is linked.